IndiaInfoline » Markets » SPARC

Sun Pharma Advanced Research Company Ltd - Share Price

SPARC

Open

226.20

Prev. Close

228.75

Turnover (lac.)

1,112

Day's High

231.90

Day's Low

226.20

52 Week's High

264.90

52 Week's Low

141.00

Book Value

-6

Face Value

1

Mkt Cap (Cr.)

5,972

P/E

0

EPS

0

Divi. Yield

0

Sun Pharma Advanced Research Company LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Sun Pharma Advanced Research Company LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Gujarat Gas Ltd654.9535.3245,048.25349.930.313,428.9265.12
Tube Investments of India Ltd1,157.8577.3922,338.29129.120.301,396.35118.93
Computer Age Management Services Ltd2,777.3061.8513,542.9853.191.84189.1996.21
Affle India Ltd4,588.55433.5512,235.9110.690.0072.23297.63
Godrej Agrovet Ltd616.6542.4611,843.6633.551.30956.3291.41

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Sun Pharma Advanced Research Company LtdSummary & Reports

No Company Summary found

Registered Office

Sun Pharma Advanced Res Centre,Akota Road Akota,Vadodara, Gujarat,390020

Tell. : +91-265-2330815/2339257
Website : http://www.sparc.life
Email : secretarial@sparcmail.com

Registrar Office

C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA

Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in

Reports by sun-pharma-advanced-research-company-ltd-share-price

Latest Release by sun-pharma-advanced-research-company-ltd-share-price

View

- <

Reco. Price

Jun 23,2021 11:25 AM

Target Price

Target Returns:

0.00%

Result Express

Sun Pharma Advanced Research Company Ltd's Q2FY19 standalone net loss narrows to Rs2.58cr yoy : Misses Estimates

Jun 25, 2021 02:39 AM

The company’s standalone revenue stood at Rs61.35cr, up 299.41% yoy and 264.96% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    EGM

    Exp. Date

    08 Jun 2021

    Annc. Date

    12 May 2021

    EGM 08/06/2021Outcome of Board Meeting pursuant to Regulation 30 of the Securities and Exchange Boar... More

  • Purpose

    Board Meeting

    Exp. Date

    25 May 2021

    Annc. Date

    25 May 2021

    Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 20... More

  • Purpose

    Board Meeting

    Exp. Date

    17 May 2021

    Annc. Date

    09 May 2021

    SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors... More